These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria. Pengpis N; Prueksrisakul T; Chanswangphuwana C Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e167-e173. PubMed ID: 36173715 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic response of oral chronic graft-versus-host disease to topical corticosteroids according to the 2014 National Institutes of Health (USA) consensus criteria. Siripornkitti W; Pengpis N; Chanswangphuwana C; Prueksrisakul T Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e219-e226. PubMed ID: 37823294 [TBL] [Abstract][Full Text] [Related]
12. Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies. Nguyen JT; Jessri M; Costa-da-Silva AC; Sharma R; Mays JW; Treister NS Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408739 [TBL] [Abstract][Full Text] [Related]
13. Recent advances and research progress in biomarkers for chronic graft versus host disease. Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073 [TBL] [Abstract][Full Text] [Related]
14. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924 [TBL] [Abstract][Full Text] [Related]
15. Novel pre-clinical mouse models for chronic Graft-versus-Host Disease. Verlaat L; Riesner K; Kalupa M; Jung B; Mertlitz S; Schwarz C; Mengwasser J; Fricke C; Penack O Front Immunol; 2022; 13():1079921. PubMed ID: 36761159 [TBL] [Abstract][Full Text] [Related]
16. Oral Complications of Chronic Graft-Versus-Host Disease. Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593 [TBL] [Abstract][Full Text] [Related]
17. A Review of Oral Chronic Graft-Versus-Host Disease: Considerations for dental hygiene practice. Johnson LB; Oh U; Rothen M; Sroussi HY; Dean DR; Lloid CM; Cintron K; Lee SJ; Cutler CS; Treister NS J Dent Hyg; 2022 Apr; 96(2):6-17. PubMed ID: 35418491 [No Abstract] [Full Text] [Related]
18. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433 [TBL] [Abstract][Full Text] [Related]
19. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy. Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Badawy SM; Bhatt N; Bhatt VR; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Hashmi S; Hematti P; Hossain NM; Inamoto Y; Lekakis LJ; Sharma A; Solomon S; Lee SJ; Couriel DR Transplant Cell Ther; 2024 Jan; 30(1):97.e1-97.e14. PubMed ID: 37844687 [TBL] [Abstract][Full Text] [Related]
20. Ocular graft-versus-host disease (oGVHD): From A to Z. Soleimani M; Mahdavi Sharif P; Cheraqpour K; Koganti R; Masoumi A; Baharnoori SM; Salabati M; Djalilian AR Surv Ophthalmol; 2023; 68(4):697-712. PubMed ID: 36870423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]